The Swiss medtech inustry says it is successful abroad but struggling in Switzerland.
Swiss medtech is successful abroad but struggling in Switzerland.
Keystone / Gaetan Bally
Fewer new jobs, less investment: the boom times for Swiss medtech firms appear to be over.
Generated with artificial intelligence.
This content was published on
La pression sur les coûts et la concurrence étrangère freinent la branche, qui anticipe néanmoins un rebond dès 2026. Le chiffre…
Swiss technology industry reports sharp rebound in new orders and growth in both sales and exports.
The pharma industry is a mainstay of the Swiss economy and a global heavyweight. But the rise of new players could shake things…
Swiss precision and electrical engineering companies show strong resilience despite geopolitical risks.
Boss of Swiss pharma research association bemoans political pressure of drug prices.
Almost three quarters of small and medium-sized enterprises (SMEs) in the machinery, electrical equipment and metals (MEM)…
La pharma suisse, dangereux trompe-l’œil industriel - Le Temps
